Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Net Asset Momentum
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) recorded a net asset momentum of -6.0% as of December 2025, with net assets of CN¥5.66 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) tangible net worth to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Net Asset Momentum (2011–2025)
This chart tracks Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is -6.0%, with net assets of CN¥5.66 Billion CNY as of December 2025. Read Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
The table below shows the complete annual net asset history for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 002932 stock market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥5.66 Billion | CN¥5.98 Billion | CN¥324.56 Million | ▼ -6.0% |
| 2024 | CN¥6.02 Billion | CN¥6.59 Billion | CN¥574.40 Million | ▼ -4.3% |
| 2023 | CN¥6.29 Billion | CN¥7.39 Billion | CN¥1.09 Billion | ▼ -7.1% |
| 2022 | CN¥6.77 Billion | CN¥9.19 Billion | CN¥2.42 Billion | ▲ +137.6% |
| 2021 | CN¥2.85 Billion | CN¥3.42 Billion | CN¥567.02 Million | ▲ +155.6% |
| 2020 | CN¥1.11 Billion | CN¥1.43 Billion | CN¥311.77 Million | ▲ +81.1% |
| 2019 | CN¥615.62 Million | CN¥638.42 Million | CN¥22.80 Million | ▲ +3.9% |
| 2018 | CN¥592.59 Million | CN¥617.15 Million | CN¥24.55 Million | ▲ +143.9% |
| 2017 | CN¥242.93 Million | CN¥256.54 Million | CN¥13.60 Million | ▲ +38.8% |
| 2016 | CN¥175.08 Million | CN¥197.15 Million | CN¥22.07 Million | ▲ +51.7% |
| 2015 | CN¥115.39 Million | CN¥133.96 Million | CN¥18.57 Million | ▲ +132.7% |
| 2014 | CN¥49.59 Million | CN¥61.01 Million | CN¥11.42 Million | ▲ +264.7% |
| 2013 | CN¥13.60 Million | CN¥23.79 Million | CN¥10.19 Million | ▲ +855.2% |
| 2012 | CN¥1.42 Million | CN¥4.66 Million | CN¥3.23 Million | ▲ +6535.8% |
| 2011 | CN¥21.45K | CN¥1.96 Million | CN¥1.94 Million | — |